clofibrate has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frohlich, B; Ma, YH; Markham, B; Roman, RJ | 1 |
| McCarthy, ET; Sharma, M; Sharma, R | 1 |
| Chang, HH; Du, J; Huang, H; Wang, CY; Wang, MH; Wu, JF; Zhou, Y | 1 |
| Ishizuka, T; Ito, O; Ito, S; Kanazawa, M; Kohzuki, M; Minami, N; Nakamura, Y; Sasaki, Y; Sasano, H; Tan, L | 1 |
| Desai, KM; Glaeser, H; Kim, RB; Sankaralingam, S; Wilson, TW | 1 |
| Chang, HH; Dong, Z; Huang, H; Luo, P; Wang, CY; Wang, MH; Yang, T; Zhou, Y | 1 |
| Chang, HH; Inscho, EW; Luo, P; Seki, T; Wang, CY; Wang, MH; Zhang, J; Zhou, Y | 1 |
7 other study(ies) available for clofibrate and 20-hydroxy-5,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.
Topics: Animals; Arachidonic Acid; Blood Pressure; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Drug Resistance; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Lipids; Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Sodium Chloride | 1993 |
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
Topics: Animals; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Glomerular Filtration Rate; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney Glomerulus; Male; Permeability; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 2005 |
Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
Topics: Animals; Blood Pressure; Clofibrate; Cytochrome P-450 CYP4A; Dietary Fats; Enzyme Induction; Hydroxyeicosatetraenoic Acids; Hypertension; Hypolipidemic Agents; Kidney; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium | 2006 |
Expression of cytochrome P-450 4 enzymes in the kidney and liver: regulation by PPAR and species-difference between rat and human.
Topics: Animals; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Humans; Hydroxyeicosatetraenoic Acids; Immunohistochemistry; Kidney; Liver; Male; Peroxisome Proliferator-Activated Receptors; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Species Specificity; Thiazolidinediones | 2006 |
Inability to upregulate cytochrome P450 4A and 2C causes salt sensitivity in young Sprague-Dawley rats.
Topics: Aging; Animals; Anticholesteremic Agents; Blood Pressure; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Male; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Sodium Chloride; Up-Regulation | 2006 |
Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.
Topics: Animals; Blood Pressure; Clofibrate; Cytochrome P-450 CYP4A; Desoxycorticosterone; Hydroxyeicosatetraenoic Acids; Hypernatremia; Hypertension; Kidney Tubules; Mice; Mice, Knockout; PPAR alpha; Sodium Chloride | 2008 |
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Topics: 8,11,14-Eicosatrienoic Acid; Amino Acids; Animals; Clofibrate; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epoxide Hydrolases; Epoxy Compounds; Hydroxyeicosatetraenoic Acids; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Glomerulus; Male; Polymerase Chain Reaction; Protein Isoforms; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Streptozocin; Transforming Growth Factor beta1 | 2009 |